Wipro among 5 stocks that can tumble up to 37%: BNP Paribas – Sell Calls

Divi’s Laboratories faces a 30% downside, with BNP Paribas setting a Rs 4,139 target price versus its current price of Rs 5,884. The brokerage believes pharma valuations have become excessive, with Divi’s trading at 77x FY25 P/E. While earnings growth is expected at 24% CAGR through FY27,…